E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Add to balance / Manage account  User:  Log out
Prospect News home > News index > List of issuers A > Headlines for AlgoRx Pharmaceuticals, Inc. > News item
Published on 12/15/2005 in the Prospect News Biotech Daily.

AlgoRx Pharmaceuticals cancels IPO

By Ted A. Knutson

Washington, Dec. 15 - AlgoRx Pharmaceuticals, Inc. canceled its planned $75 million initial public offering after citing changed market conditions in an RW registration with the Securities and Exchange Commission.

Credit Suisse First Boston and Citigroup were to have been the co-bookrunners with participation from Piper Jaffray and Lazard.

The Secaucus, N.J.-based company is developing drugs to lessen pain.


© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.